Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease

Max A. Villain; Georges P. Pageaux; Michel Veyrac; Bernard Arnaud; Alon Harris; David S. Greenfield

doi:10.1016/S0002-9394(02)01650-1

Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease

Max A. Villain, Georges P. Pageaux, Michel Veyrac, Bernard Arnaud, Alon Harris, David S. Greenfield

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

PURPOSE: To describe the hemodynamic effect of oral acetazolamide administration on ocular perfusion in a patient with pseudotumor cerebri associated with Crohn disease. DESIGN: Interventional case report. METHODS: A 20-year-old woman with a 5-year history of Crohn disease presented with a 2-week history of headache and blurred vision in both eyes. Ophthalmologic examination was normal. Fluorescein angiography showed a profound delay in retinal and choroidal perfusion. Lumbar puncture showed an opening pressure of 320 mm water. Therapy was initiated with oral acetazolamide 750 mg per day. RESULTS: A subjective improvement of symptoms was noted over 4 days. Repeat fluorescein angiography showed resolution of the ocular perfusion deficit. No recurrent symptoms were noted 19 months after cessation of therapy. CONCLUSIONS: Crohn disease may present with pseudotumor cerebri and severe ocular perfusion deficits that are reversible with oral acetazolamide therapy.

Original language	English
Pages (from-to)	778-780
Number of pages	3
Journal	American Journal of Ophthalmology
Volume	134
Issue number	5
DOIs	https://doi.org/10.1016/S0002-9394(02)01650-1
State	Published - 1 Nov 2002
Externally published	Yes

Access to Document

10.1016/S0002-9394(02)01650-1

Cite this

@article{fe6eb36b70914937a14cddca9da9ed95,

title = "Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease",

abstract = "PURPOSE: To describe the hemodynamic effect of oral acetazolamide administration on ocular perfusion in a patient with pseudotumor cerebri associated with Crohn disease. DESIGN: Interventional case report. METHODS: A 20-year-old woman with a 5-year history of Crohn disease presented with a 2-week history of headache and blurred vision in both eyes. Ophthalmologic examination was normal. Fluorescein angiography showed a profound delay in retinal and choroidal perfusion. Lumbar puncture showed an opening pressure of 320 mm water. Therapy was initiated with oral acetazolamide 750 mg per day. RESULTS: A subjective improvement of symptoms was noted over 4 days. Repeat fluorescein angiography showed resolution of the ocular perfusion deficit. No recurrent symptoms were noted 19 months after cessation of therapy. CONCLUSIONS: Crohn disease may present with pseudotumor cerebri and severe ocular perfusion deficits that are reversible with oral acetazolamide therapy.",

author = "Villain, {Max A.} and Pageaux, {Georges P.} and Michel Veyrac and Bernard Arnaud and Alon Harris and Greenfield, {David S.}",

year = "2002",

month = nov,

day = "1",

doi = "10.1016/S0002-9394(02)01650-1",

language = "English",

volume = "134",

pages = "778--780",

journal = "American Journal of Ophthalmology",

issn = "0002-9394",

publisher = "Elsevier USA",

number = "5",

}

TY - JOUR

T1 - Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease

AU - Villain, Max A.

AU - Pageaux, Georges P.

AU - Veyrac, Michel

AU - Arnaud, Bernard

AU - Harris, Alon

AU - Greenfield, David S.

PY - 2002/11/1

Y1 - 2002/11/1

N2 - PURPOSE: To describe the hemodynamic effect of oral acetazolamide administration on ocular perfusion in a patient with pseudotumor cerebri associated with Crohn disease. DESIGN: Interventional case report. METHODS: A 20-year-old woman with a 5-year history of Crohn disease presented with a 2-week history of headache and blurred vision in both eyes. Ophthalmologic examination was normal. Fluorescein angiography showed a profound delay in retinal and choroidal perfusion. Lumbar puncture showed an opening pressure of 320 mm water. Therapy was initiated with oral acetazolamide 750 mg per day. RESULTS: A subjective improvement of symptoms was noted over 4 days. Repeat fluorescein angiography showed resolution of the ocular perfusion deficit. No recurrent symptoms were noted 19 months after cessation of therapy. CONCLUSIONS: Crohn disease may present with pseudotumor cerebri and severe ocular perfusion deficits that are reversible with oral acetazolamide therapy.

AB - PURPOSE: To describe the hemodynamic effect of oral acetazolamide administration on ocular perfusion in a patient with pseudotumor cerebri associated with Crohn disease. DESIGN: Interventional case report. METHODS: A 20-year-old woman with a 5-year history of Crohn disease presented with a 2-week history of headache and blurred vision in both eyes. Ophthalmologic examination was normal. Fluorescein angiography showed a profound delay in retinal and choroidal perfusion. Lumbar puncture showed an opening pressure of 320 mm water. Therapy was initiated with oral acetazolamide 750 mg per day. RESULTS: A subjective improvement of symptoms was noted over 4 days. Repeat fluorescein angiography showed resolution of the ocular perfusion deficit. No recurrent symptoms were noted 19 months after cessation of therapy. CONCLUSIONS: Crohn disease may present with pseudotumor cerebri and severe ocular perfusion deficits that are reversible with oral acetazolamide therapy.

UR - http://www.scopus.com/inward/record.url?scp=0036844822&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(02)01650-1

DO - 10.1016/S0002-9394(02)01650-1

M3 - Article

C2 - 12429264

AN - SCOPUS:0036844822

SN - 0002-9394

VL - 134

SP - 778

EP - 780

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

IS - 5

ER -

Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease

Abstract

Access to Document

Fingerprint

Cite this